Brand: ProteoGenix

Ipilimumab Biosimilar – Anti-CTLA-4 mAb – Research Grade

PX-TA1021

Isotype:: IgG1, kappa

$143.00

+ 143 loyalty points

Size Size

100ug $143.00
1MG $315.00
10mg $1,577.00
25mg $3,314.00

First Name This field is required. Last Name This field is required. Email This field is required. Company This field is required. Country This field is required. State This field is required.

In Stock
Wide range of unique reagents
Fast worldwide delivery

Ipilimumab Biosimilar - Anti-CTLA-4 mAb - Research Grade

Product name	Ipilimumab Biosimilar - Anti-CTLA-4 mAb - Research Grade
Source	DrugBank DB06186
Species	Human
Molecular weight	148kDa
Purity	>85%
Buffer	PBS pH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	4°C for short term; -20°C for long term
Brand	ProteoGenix
Applications	ELISA,WB
Aliases /Synonyms	Ipilimumab,Ipilimumab,CTLA-4,anti-CTLA-4
Reference	PX-TA1021
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG1Kappa
Clonality	Monoclonal Antibody

Product name	Ipilimumab Biosimilar - Anti-CTLA-4 mAb - Research Grade
Source	DrugBank DB06186
Species	Human
Molecular weight	148kDa
Purity	>85%
Buffer	PBS pH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	4°C for short term; -20°C for long term
Brand	ProteoGenix
Applications	ELISA,WB,,,
Aliases /Synonyms	Ipilimumab,Ipilimumab,CTLA-4,anti-CTLA-4
Reference	PX-TA1021
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG1Kappa
Clonality	Monoclonal Antibody

General information about Ipilimumab

Ipilimumab is a monoclonal antibody used in the treatment of melanoma. It is an antibody that inhibits the CTLA-4 checkpoint of T lymphocytes, a checkpoint that certain cancers activate to decrease the efficiency of the lymphocyte. Ipilimumab is a human monoclonal antibody of the IgG1 type directed against the CTLA-4 protein (Cytotoxic T-Lymphocyte Antigen 4). The inhibition of this receptor present on the T lymphocytes results in the activation of the T lymphocyte. This product is for research use only.

There are no reviews yet.

Be the first to review “Ipilimumab Biosimilar – Anti-CTLA-4 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Your rating *

In which application did you use the antibody? *

Did it work in your application? * Yes No

Your review *

Name *

Email *

Ipilimumab Biosimilar – Anti-CTLA-4 mAb – Research Grade

Ipilimumab Biosimilar - Anti-CTLA-4 mAb - Research Grade

General information about Ipilimumab

Related products

CTLA-4 Protein- Cytotoxic T-lymphocyte protein 4 recombinant protein

Cytotoxic T-lymphocyte protein 4(CTLA4)(Ala37-Asp161)

Human CD80, B7-1 recombinant protein

Human CD86, B7-2 recombinant protein

Mouse CTLA-4 recombinant protein

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

Anti-Ipilimumab Polyclonal Antibody

Ipilimumab ELISA Kit

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Ipilimumab Biosimilar – Anti-CTLA-4 mAb – Research Grade

Specifications Ipilimumab Biosimilar - Anti-CTLA-4 mAb - Research Grade

Description

General information about Ipilimumab

Documents

Reviews

Related products

CTLA-4 Protein- Cytotoxic T-lymphocyte protein 4 recombinant protein

Cytotoxic T-lymphocyte protein 4(CTLA4)(Ala37-Asp161)

Human CD80, B7-1 recombinant protein

Human CD86, B7-2 recombinant protein

Mouse CTLA-4 recombinant protein

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

Anti-Ipilimumab Polyclonal Antibody

Ipilimumab ELISA Kit

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Ipilimumab Biosimilar - Anti-CTLA-4 mAb - Research Grade